The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Needle-Free Drug Delivery Devices Market Progress Between 2026 And 2030?
The needle-free drug delivery devices market size has seen swift expansion in recent years. It is projected to increase from $18.54 billion in 2025 to $20.65 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.4%. This historical growth can be attributed to factors such as needle phobia among patients, a demand for safer injection alternatives, an increase in infectious disease vaccinations, the limitations of traditional needle-based methods, and early advancements in jet injection mechanisms.
The needle-free drug delivery devices market size is projected to undergo significant expansion over the next few years, reaching $29.91 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. This anticipated growth can be linked to factors such as the increasing prevalence of chronic diseases, a growing embrace of self-administration therapies, the expansion of telemedicine and remote care services, an escalating demand for minimally invasive drug delivery solutions, and advancements in both microneedle and transdermal technologies. Prominent trends expected during this forecast period include an increasing requirement for painless drug delivery methods, a rise in the adoption of home-based drug delivery solutions, the growing utilization of needle-free devices in pediatric applications, an increase in self-administration treatments for chronic conditions, and the broadening of needle-free vaccine delivery systems.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp
Which Major Drivers Are Influencing The Expansion Of The Needle-Free Drug Delivery Devices Market?
The rising occurrence of diabetes is projected to fuel the expansion of the needle-free drug delivery device market in the future. Diabetes is a chronic health condition characterized by elevated blood glucose levels, resulting from insufficient insulin generation or the body’s inefficient use of insulin. The incidence of diabetes is increasing globally due to factors such as inactive lifestyles, poor eating habits, genetic susceptibility, urban development, and an aging demographic, further exacerbated by restricted access to medical services and growing obesity rates across the globe. For managing diabetes, needle-free drug delivery devices offer an alternative to traditional injectable methods for insulin delivery. These devices employ technologies like jet injectors or transdermal patches to administer insulin through the skin without requiring needles, thereby reducing the unease and apprehension commonly associated with injections and improving patient comfort. For example, in June 2024, data from the National Health Service, a UK-based government department, revealed that in 2023, the NHS identified over half a million (549,000) new individuals in England facing a risk of developing type 2 diabetes. This raised the total count of people diagnosed with non-diabetic hyperglycemia, or pre-diabetes, and registered with a GP to 3,615,330. This figure marks a substantial rise from 3,065,825 recorded in 2022, indicating an increase of nearly 20%. Consequently, the growing occurrence of diabetes is propelling the expansion of the needle-free drug delivery device market.
How Is The Needle-Free Drug Delivery Devices Market Broken Down By Segment Categories?
The needle-free drug delivery devices market covered in this report is segmented –
1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches
2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications
3) By End-User: Hospitals And Clinics, Home Healthcare
Subsegments:
1) By Inhalers: Dry Powder Inhalers (DPI), Metered Dose Inhalers (MDI), Nebulizers
2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors
3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays
4) By Transdermal Patches: Microneedle Patches, Conventional Patches
Which Trends Are Shaping The Needle-Free Drug Delivery Devices Market?
Leading companies within the needle-free drug delivery device market are concentrating on advanced solutions, like dual-chamber inhalers, to elevate efficacy and ease of administration while meeting the changing demands of patients and healthcare providers. A dual-chamber inhaler is a device featuring two separate compartments for different medications, allowing for the combination of multiple drugs in a single unit, which streamlines treatment and improves patient convenience. For example, in April 2024, Berry Global, a US-based plastic manufacturing company, introduced the BerryHaler, an innovative dry powder inhaler (DPI) designed to enhance patient-centered healthcare. This dual-chamber inhaler integrates a dose counter for precise medication delivery. Its all-plastic construction, devoid of metal components, renders it ideal for complex inhalation treatments, simplifying dosing and effectively merging various drugs. Its advanced attributes include a bi-directional mouthpiece cover for convenience and hygiene, alongside audible signals to confirm proper usage. The built-in dose counter assists in accurately monitoring medication usage, thus preventing dosage errors.
Which Players Are Present In The Needle-Free Drug Delivery Devices Market Space?
Major companies operating in the needle-free drug delivery devices market are 3M Company, Medtronic plc, Novo Nordisk AS, Becton Dickinson and Company, Insulet Corporation, MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG, Bayer AG, Antares Pharma Inc., Inovio Pharmaceuticals Inc.
Get The Full Needle-Free Drug Delivery Devices Market Report:
Which Region Leads The Needle-Free Drug Delivery Devices Market In Terms Of Market Share?
North America was the largest region in the needle-free drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Needle-Free Drug Delivery Devices Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Needle-Free Drug Delivery Devices Market 2026, By The Business Research Company
Rotavirus Prophylaxis Market Report 2026
https://www.thebusinessresearchcompany.com/report/rotavirus-prophylaxis-global-market-report
Appendicitis Treatment Market Report
https://www.thebusinessresearchcompany.com/report/appendicitis-treatment-global-market-report
Automotive Fascia Market Report
https://www.thebusinessresearchcompany.com/report/automotive-fascia-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model